Design, synthesis, and biological evaluation of dinuclear bismuth(III) complexes with Isoniazid-derived Schiff bases

J Inorg Biochem. 2022 Oct:235:111931. doi: 10.1016/j.jinorgbio.2022.111931. Epub 2022 Jul 16.

Abstract

Four dinuclear bismuth(III) Schiff-base complexes bearing Schiff-base ligands have been synthesized and structurally characterized by single-crystal X-ray diffraction, elemental analysis, and spectral techniques (FT-IR, NMR and MS). The analytical data reveal the bismuth(III) complexes possess 1:1 metal-ligand ratios. In vitro biological studies have revealed that bismuth(III) complexes displayed much higher antibacterial and antitumor activities than their parent ligands, which involves two gram-negative (S. aureus, B. subtili) and two gram-positive (E. coli, P. aeruginosa) bacteria, and human gastric cancer SNU-16 cells. The power-time curves of S. pombe exposed to tested compounds were detected by bio-microcalorimetry. Some thermokinetic parameters (k, Pmax,tG and Qtotal) were derived based on the metabolic power-time curves, and their quantitative relationships with the concentrations (c) were further discussed.

Keywords: Antibacterial activity; Bio-microcalorimetry; Bismuth(III) complex; Cytotoxic activity; Schiff base; Thermokinetic parameters.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Bismuth / pharmacology
  • Coordination Complexes* / chemistry
  • Escherichia coli
  • Humans
  • Isoniazid / pharmacology
  • Ligands
  • Microbial Sensitivity Tests
  • Schiff Bases* / chemistry
  • Spectroscopy, Fourier Transform Infrared
  • Staphylococcus aureus

Substances

  • Anti-Bacterial Agents
  • Coordination Complexes
  • Ligands
  • Schiff Bases
  • Bismuth
  • Isoniazid